REMS - Pharmacy Network List The REMS - Pharmacy Network list includes specialty pharmacies that are contracted to fill prescriptions for restricted distribution programs for Celgene. All pharmacies listed are certified to dispense all Celgene REMS products. Version: May 2014 – Please check

For more information about the THALOMID REMS ® program, please visit www.CelgeneRiskManagement.com or call 1-888-423-5436. Your Celgene Patient Support ® Specialist can provide information on which pharmacy is in-network with your insurer. How can I get more information about THALOMID ®? Your healthcare team is the best source of information.

For more information about ABECMA REMS, call 1-888-423-5436.. RESOURCES To avoid embryo-fetal exposure, REVLIMID is only available through a restricted distribution program called the REVLIMID Risk Evaluation and Mitigation Strategy (REMS) ® program. The REVLIMID REMS ® program requires prescribers and pharmacies to be certified and patients to enroll and comply with all of the program requirements.. To enroll yourself and your patients, receive more information REVLIMID REMS. To avoid serious risks to unborn babies, REVLIMID is only available through a restricted distribution program called REVLIMID Risk Evaluation and Mitigation Strategy (REMS) program. Before you are prescribed REVLIMID, you must be enrolled in the REVLIMID REMS program.

Download REMS Companion App App 1.0 for iPhone free online at AppPure. Get REMS Companion App for iOS latest version. This is the FDA approved national launch version of the REMS Companion App. Bristol Myers Squibb offers three legacy Celgene products with REMS programs that also include ETASU: Revlimid ® (lenalidomide), Pomalyst ® (pomalidomide) and Thalomid ® (thalidomide). The goals of these REMS are to prevent the risk of embryo exposure to Revlimid, Pomalyst, and Thalomid and to inform prescribers, patients, and pharmacists on the serious risks and safe-use conditions for 6 REVLIMID REMS® patient enrollment • Obtain, review, and complete the REVLIMID® (lenalidomide) Patient-Physician Agreement Form online by visiting www.CelgeneRiskManagement.com, accessing the Celgene REMS mobile app, or by calling the Celgene Customer Care Center for assistance at 1-888-423-5436 • Prescribers who do not have access to a computer will be provided with REVLIMID REMS® … The REMS Companion App is a new application application that will allow patients, who reside within the United States, to conduct Risk Evaluation and Mitigation Strategy (REMS) patient surveys.

Celgene does not collect personal information for marketing purposes without your consent. REVLIMID REMS.

For additional information about the REVLIMID REMS ® program, please contact the Celgene Customer Care Center at 1-888-423-5436.

For additional information about the REVLIMID REMS ® program, please contact the Celgene Customer Care Center at 1-888-423-5436 Download REMS Companion App App 1.0 for iPhone free online at AppPure. Get REMS Companion App for iOS latest version. This is the FDA approved national launch version of the REMS Companion App. For more information about the REVLIMID REMS ® program, please visit www.CelgeneRiskManagement.com or call 1-888-423-5436. Your Celgene Patient Support ® Specialist can provide information on which pharmacy is in-network with your insurer.

Download the Celgene REMS mobile app to your iPad by clicking here: Patient Resources THALOMID ® (thalidomide) in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM).

Additionally, do not edit any Celgene REMS file or folder names after installation.

Vérification Plus de Celgene Corporation.
Schema tävelsås skola

Fast Track for First Prescription®: Yes No Patient’s Celgene REMS Authorization Number PATIENT INFORMATION *First Name Middle Name *Address 1 Address 2 *City *State *Zip Code Get started in the Celgene Patient Support® program by downloading our enrollment form, in English or Spanish, and then submitting online or faxing it back.

POMALYST ® (pomalidomide) is only dispensed from POMALYST REMS ® program certified pharmacies. To learn more about how to become a certified pharmacy, please contact the Celgene Customer Care Center at 1-888-423-5436. Download the Celgene REMS mobile app to your iPad by clicking here: About the REVLIMID REMS ® program To avoid embryo-fetal exposure, REVLIMID is only available under a restricted distribution program called "REVLIMID Risk Evaluation and Mitigation Strategy (REMS)." Access ABECMA REMS Training Program and Knowledge Assessment: HEALTHCARE FACILITY STAFF Access ABECMA REMS online resources: AUTHORIZED REPRESENTATIVES CONTACT.
Hälsa så gott tillbaka

In order to prescribe REVLIMID, you must enroll in the REVLIMID REMS ® program and agree to follow the requirements of the program. You can enroll by visiting CelgeneRiskManagement.com , a website that allows prescribers to handle the REMS process for all of the Celgene REMS programs.

Your healthcare team is the best source of information. Celgene: REMS with ETASU Celgene has three products with REMS programs that also include ETASU: Revlimid ® (lenalidomide), Pomalyst (pomalidomide) and Thalomid® (thalidomide). The goals of these REMS are to prevent the risk of embryo exposure to Revlimid, Pomalyst, and Thalomid and to inform prescribers, patients, and pharmacists on the serious 2017-06-27 Celgene Corporation, a Bristol Myers Squibb company, at 1-888-423-5436.

Omskärelse pris vuxen

För riskhanteringsaktiviteter som genomförs i USA via våra REMS-program (Risk Evaluation and Mitigation Strategy) har Celgene infört ett antal innovativa

At Celgene Patient Support ®, we care about making sure you get the answers you need.